Cycloalkenyl aryl derivatives for CETP inhibitor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9371294
APP PUB NO 20140031335A1
SERIAL NO

14110271

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to cycloalkenyl aryl derivatives, isomers thereof, pharmaceutically acceptable salts thereof, hydrates thereof, or solvates thereof; a method for preparing the derivatives; and pharmaceutical compositions containing the same. The compounds of the present invention show the effect of CETP activity inhibition. It means that the compounds can increase HDL-cholesterol and decrease LDL-cholesterol.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHONG KUN DANG PHARMACEUTICAL CORPSEOUL

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bae, Suyeal Yongin-si, KR 3 7
Ha, Nina Yongin-si, KR 15 17
Lee, JaeKwang Yongin-si, KR 34 191
Lee, JaeWon Yongin-si, KR 119 611
Lee, SeoHee Yongin-si, KR 1 3
Lee, Sera Yongin-si, KR 5 3
Oh, Jung Taek Yongin-si, KR 16 110

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 21, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00